Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hope that other groups are!
Great question. Two problems with making a therapeutic antibody against seven KC. One is that we are not sure how good the seven KC antibodies are yet. We are working on this. The problem there is that 7KC only differs…
Hi, I'm co-founder of Underdog and the scientist who invented the drugs we are developing. Cool that this community has taken an interest. I agree with a lot of the insightful comments here. If you're interested in…
Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hope that other groups are!
Great question. Two problems with making a therapeutic antibody against seven KC. One is that we are not sure how good the seven KC antibodies are yet. We are working on this. The problem there is that 7KC only differs…
Hi, I'm co-founder of Underdog and the scientist who invented the drugs we are developing. Cool that this community has taken an interest. I agree with a lot of the insightful comments here. If you're interested in…